Ameriprise Financial Inc. lessened its stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 17.1% in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,527,363 shares of the real estate investment trust's stock after selling 1,144,128 shares during the quarter. Ameriprise Financial Inc. owned approximately 0.80% of Healthpeak Properties worth $109,906,000 at the end of the most recent reporting period.
A number of other large investors also recently added to or reduced their stakes in the stock. Nuveen LLC acquired a new stake in shares of Healthpeak Properties in the first quarter valued at about $124,113,000. Resolution Capital Ltd purchased a new position in Healthpeak Properties during the 4th quarter valued at about $122,795,000. Invesco Ltd. increased its stake in Healthpeak Properties by 20.7% during the 1st quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust's stock worth $467,311,000 after buying an additional 3,967,830 shares during the period. Northern Trust Corp raised its stake in shares of Healthpeak Properties by 32.6% in the fourth quarter. Northern Trust Corp now owns 10,526,223 shares of the real estate investment trust's stock valued at $213,367,000 after acquiring an additional 2,590,530 shares in the last quarter. Finally, Centersquare Investment Management LLC boosted its stake in shares of Healthpeak Properties by 18.5% in the 1st quarter. Centersquare Investment Management LLC now owns 13,285,932 shares of the real estate investment trust's stock valued at $268,642,000 after buying an additional 2,070,416 shares during the period. 93.57% of the stock is currently owned by institutional investors and hedge funds.
Healthpeak Properties Stock Performance
Healthpeak Properties stock traded up $0.03 during midday trading on Friday, hitting $17.89. 2,436,136 shares of the company's stock were exchanged, compared to its average volume of 6,072,793. The stock has a market cap of $12.43 billion, a price-to-earnings ratio of 74.52, a price-to-earnings-growth ratio of 2.30 and a beta of 1.05. Healthpeak Properties, Inc. has a 12-month low of $16.63 and a 12-month high of $23.26. The firm's 50 day simple moving average is $17.68 and its 200 day simple moving average is $18.32. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.28 and a current ratio of 1.28.
Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting the consensus estimate of $0.46. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The company had revenue of $694.35 million for the quarter, compared to the consensus estimate of $697.14 million. During the same period last year, the business posted $0.45 EPS. The company's revenue was down .2% on a year-over-year basis. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Equities research analysts predict that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.
Healthpeak Properties Dividend Announcement
The company also recently announced a monthly dividend, which will be paid on Friday, August 29th. Stockholders of record on Monday, August 18th will be paid a $0.1017 dividend. This represents a c) annualized dividend and a dividend yield of 6.8%. The ex-dividend date is Monday, August 18th. Healthpeak Properties's dividend payout ratio (DPR) is 508.33%.
Wall Street Analyst Weigh In
A number of brokerages have recently weighed in on DOC. Robert W. Baird set a $21.00 price objective on shares of Healthpeak Properties and gave the stock an "outperform" rating in a research report on Wednesday, July 30th. Wall Street Zen lowered Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Monday, July 7th. Morgan Stanley decreased their price target on Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating for the company in a report on Friday, August 22nd. Wells Fargo & Company dropped their price objective on Healthpeak Properties from $20.00 to $18.00 and set an "equal weight" rating on the stock in a report on Wednesday. Finally, Scotiabank lowered Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and cut their target price for the stock from $21.00 to $19.00 in a research report on Tuesday, July 29th. Seven equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $21.50.
Get Our Latest Research Report on Healthpeak Properties
Insider Buying and Selling at Healthpeak Properties
In other news, CEO Scott M. Brinker purchased 1,490 shares of the company's stock in a transaction dated Monday, August 4th. The shares were acquired at an average cost of $16.83 per share, for a total transaction of $25,076.70. Following the completion of the purchase, the chief executive officer directly owned 211,906 shares in the company, valued at $3,566,377.98. The trade was a 0.71% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have bought a total of 8,783 shares of company stock valued at $150,129 over the last quarter. 0.23% of the stock is owned by insiders.
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Read More

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.